1. Home
  2. LWAY vs PBMWW Comparison

LWAY vs PBMWW Comparison

Compare LWAY & PBMWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LWAY
  • PBMWW
  • Stock Information
  • Founded
  • LWAY 1986
  • PBMWW N/A
  • Country
  • LWAY United States
  • PBMWW Canada
  • Employees
  • LWAY N/A
  • PBMWW 10
  • Industry
  • LWAY Packaged Foods
  • PBMWW
  • Sector
  • LWAY Consumer Staples
  • PBMWW
  • Exchange
  • LWAY Nasdaq
  • PBMWW Nasdaq
  • Market Cap
  • LWAY N/A
  • PBMWW N/A
  • IPO Year
  • LWAY 1987
  • PBMWW N/A
  • Fundamental
  • Price
  • LWAY $22.89
  • PBMWW $0.02
  • Analyst Decision
  • LWAY Hold
  • PBMWW
  • Analyst Count
  • LWAY 1
  • PBMWW 0
  • Target Price
  • LWAY N/A
  • PBMWW N/A
  • AVG Volume (30 Days)
  • LWAY 76.5K
  • PBMWW N/A
  • Earning Date
  • LWAY 11-14-2024
  • PBMWW N/A
  • Dividend Yield
  • LWAY N/A
  • PBMWW N/A
  • EPS Growth
  • LWAY 59.90
  • PBMWW N/A
  • EPS
  • LWAY 0.86
  • PBMWW N/A
  • Revenue
  • LWAY $181,979,000.00
  • PBMWW N/A
  • Revenue This Year
  • LWAY $23.48
  • PBMWW N/A
  • Revenue Next Year
  • LWAY $11.95
  • PBMWW N/A
  • P/E Ratio
  • LWAY $26.64
  • PBMWW N/A
  • Revenue Growth
  • LWAY 18.27
  • PBMWW N/A
  • 52 Week Low
  • LWAY $9.93
  • PBMWW N/A
  • 52 Week High
  • LWAY $28.61
  • PBMWW N/A
  • Technical
  • Relative Strength Index (RSI)
  • LWAY 38.44
  • PBMWW N/A
  • Support Level
  • LWAY $23.59
  • PBMWW N/A
  • Resistance Level
  • LWAY $24.91
  • PBMWW N/A
  • Average True Range (ATR)
  • LWAY 0.85
  • PBMWW 0.00
  • MACD
  • LWAY -0.14
  • PBMWW 0.00
  • Stochastic Oscillator
  • LWAY 17.21
  • PBMWW 0.00

About PBMWW Psyence Biomedical Ltd. Warrant

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: